Armata Pharmaceuticals (FRA:TG1N) FFO


FRA:TG1N Armata Pharmaceuticals Inc FRA:TG1N
27 GF Score
Price €5.05
! 3 Warning Signs
View Full Analysis

What is Armata Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

FRA:TG1N
27GF Score
Armata Pharmaceuticals Inc FRA:TG1N
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Armata Pharmaceuticals Business Description

Other Exchanges ARMP:USATG1N:Germany
Address 5005 McConnell Avenue, Los Angeles, CA, USA, 90066
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
27GF Score

Get the complete analysis for FRA:TG1N

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.05
Price